purchase customization

1 Study Coverage
1.1 Oral Transmucosal Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oral Transmucosal Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Films
1.2.4 Liquid Spray
1.2.5 Gels
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oral Transmucosal Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiovascular Disorders
1.3.3 Acute Pain Managements
1.3.4 Diabetes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Transmucosal Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Transmucosal Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Transmucosal Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Transmucosal Drugs Sales by Region
2.4.1 Global Oral Transmucosal Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Oral Transmucosal Drugs by Region (2023-2028)
2.5 Global Oral Transmucosal Drugs Revenue by Region
2.5.1 Global Oral Transmucosal Drugs Revenue by Region (2017-2022)
2.5.2 Global Oral Transmucosal Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Transmucosal Drugs Sales by Manufacturers
3.1.1 Global Top Oral Transmucosal Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Transmucosal Drugs in 2021
3.2 Global Oral Transmucosal Drugs Revenue by Manufacturers
3.2.1 Global Oral Transmucosal Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Transmucosal Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Transmucosal Drugs Revenue in 2021
3.3 Global Oral Transmucosal Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Transmucosal Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Transmucosal Drugs Sales by Type
4.1.1 Global Oral Transmucosal Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Oral Transmucosal Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
4.2 Global Oral Transmucosal Drugs Revenue by Type
4.2.1 Global Oral Transmucosal Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Transmucosal Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Oral Transmucosal Drugs Price by Type
4.3.1 Global Oral Transmucosal Drugs Price by Type (2017-2022)
4.3.2 Global Oral Transmucosal Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Transmucosal Drugs Sales by Application
5.1.1 Global Oral Transmucosal Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Oral Transmucosal Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
5.2 Global Oral Transmucosal Drugs Revenue by Application
5.2.1 Global Oral Transmucosal Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Transmucosal Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Oral Transmucosal Drugs Price by Application
5.3.1 Global Oral Transmucosal Drugs Price by Application (2017-2022)
5.3.2 Global Oral Transmucosal Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Transmucosal Drugs Market Size by Type
6.1.1 North America Oral Transmucosal Drugs Sales by Type (2017-2028)
6.1.2 North America Oral Transmucosal Drugs Revenue by Type (2017-2028)
6.2 North America Oral Transmucosal Drugs Market Size by Application
6.2.1 North America Oral Transmucosal Drugs Sales by Application (2017-2028)
6.2.2 North America Oral Transmucosal Drugs Revenue by Application (2017-2028)
6.3 North America Oral Transmucosal Drugs Market Size by Country
6.3.1 North America Oral Transmucosal Drugs Sales by Country (2017-2028)
6.3.2 North America Oral Transmucosal Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oral Transmucosal Drugs Market Size by Type
7.1.1 Europe Oral Transmucosal Drugs Sales by Type (2017-2028)
7.1.2 Europe Oral Transmucosal Drugs Revenue by Type (2017-2028)
7.2 Europe Oral Transmucosal Drugs Market Size by Application
7.2.1 Europe Oral Transmucosal Drugs Sales by Application (2017-2028)
7.2.2 Europe Oral Transmucosal Drugs Revenue by Application (2017-2028)
7.3 Europe Oral Transmucosal Drugs Market Size by Country
7.3.1 Europe Oral Transmucosal Drugs Sales by Country (2017-2028)
7.3.2 Europe Oral Transmucosal Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Transmucosal Drugs Market Size by Type
8.1.1 Asia Pacific Oral Transmucosal Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Transmucosal Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Transmucosal Drugs Market Size by Application
8.2.1 Asia Pacific Oral Transmucosal Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Transmucosal Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Transmucosal Drugs Market Size by Region
8.3.1 Asia Pacific Oral Transmucosal Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Transmucosal Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oral Transmucosal Drugs Market Size by Type
9.1.1 Latin America Oral Transmucosal Drugs Sales by Type (2017-2028)
9.1.2 Latin America Oral Transmucosal Drugs Revenue by Type (2017-2028)
9.2 Latin America Oral Transmucosal Drugs Market Size by Application
9.2.1 Latin America Oral Transmucosal Drugs Sales by Application (2017-2028)
9.2.2 Latin America Oral Transmucosal Drugs Revenue by Application (2017-2028)
9.3 Latin America Oral Transmucosal Drugs Market Size by Country
9.3.1 Latin America Oral Transmucosal Drugs Sales by Country (2017-2028)
9.3.2 Latin America Oral Transmucosal Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Transmucosal Drugs Market Size by Type
10.1.1 Middle East and Africa Oral Transmucosal Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Transmucosal Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Transmucosal Drugs Market Size by Application
10.2.1 Middle East and Africa Oral Transmucosal Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Transmucosal Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Transmucosal Drugs Market Size by Country
10.3.1 Middle East and Africa Oral Transmucosal Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Transmucosal Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 LTS Lohmann Therapie-Systeme AG
11.1.1 LTS Lohmann Therapie-Systeme AG Corporation Information
11.1.2 LTS Lohmann Therapie-Systeme AG Overview
11.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 LTS Lohmann Therapie-Systeme AG Recent Developments
11.2 Soligenix
11.2.1 Soligenix Corporation Information
11.2.2 Soligenix Overview
11.2.3 Soligenix Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Soligenix Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Soligenix Recent Developments
11.3 ZIM Laboratories Limited
11.3.1 ZIM Laboratories Limited Corporation Information
11.3.2 ZIM Laboratories Limited Overview
11.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ZIM Laboratories Limited Recent Developments
11.4 Access Pharmaceutical Inc.
11.4.1 Access Pharmaceutical Inc. Corporation Information
11.4.2 Access Pharmaceutical Inc. Overview
11.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Access Pharmaceutical Inc. Recent Developments
11.5 C.L Pharm
11.5.1 C.L Pharm Corporation Information
11.5.2 C.L Pharm Overview
11.5.3 C.L Pharm Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 C.L Pharm Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 C.L Pharm Recent Developments
11.6 Cure Pharmaceutical
11.6.1 Cure Pharmaceutical Corporation Information
11.6.2 Cure Pharmaceutical Overview
11.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cure Pharmaceutical Recent Developments
11.7 Aquestive Therapeutics, Inc.
11.7.1 Aquestive Therapeutics, Inc. Corporation Information
11.7.2 Aquestive Therapeutics, Inc. Overview
11.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aquestive Therapeutics, Inc. Recent Developments
11.8 NAL Pharma
11.8.1 NAL Pharma Corporation Information
11.8.2 NAL Pharma Overview
11.8.3 NAL Pharma Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 NAL Pharma Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 NAL Pharma Recent Developments
11.9 IntelGenx Corp.
11.9.1 IntelGenx Corp. Corporation Information
11.9.2 IntelGenx Corp. Overview
11.9.3 IntelGenx Corp. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 IntelGenx Corp. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 IntelGenx Corp. Recent Developments
11.10 Eisai Co., Ltd.
11.10.1 Eisai Co., Ltd. Corporation Information
11.10.2 Eisai Co., Ltd. Overview
11.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Eisai Co., Ltd. Recent Developments
11.11 Otsuka Pharmaceutical Co., Ltd.
11.11.1 Otsuka Pharmaceutical Co., Ltd. Corporation Information
11.11.2 Otsuka Pharmaceutical Co., Ltd. Overview
11.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
11.12 Teva Pharmaceutical Industries Ltd.
11.12.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.12.2 Teva Pharmaceutical Industries Ltd. Overview
11.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.13 GlaxoSmithKline plc
11.13.1 GlaxoSmithKline plc Corporation Information
11.13.2 GlaxoSmithKline plc Overview
11.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 GlaxoSmithKline plc Recent Developments
11.14 Viatris
11.14.1 Viatris Corporation Information
11.14.2 Viatris Overview
11.14.3 Viatris Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Viatris Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Viatris Recent Developments
11.15 Bristol-Myers Squibb Company
11.15.1 Bristol-Myers Squibb Company Corporation Information
11.15.2 Bristol-Myers Squibb Company Overview
11.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Bristol-Myers Squibb Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Transmucosal Drugs Industry Chain Analysis
12.2 Oral Transmucosal Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Transmucosal Drugs Production Mode & Process
12.4 Oral Transmucosal Drugs Sales and Marketing
12.4.1 Oral Transmucosal Drugs Sales Channels
12.4.2 Oral Transmucosal Drugs Distributors
12.5 Oral Transmucosal Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Transmucosal Drugs Industry Trends
13.2 Oral Transmucosal Drugs Market Drivers
13.3 Oral Transmucosal Drugs Market Challenges
13.4 Oral Transmucosal Drugs Market Restraints
14 Key Findings in The Global Oral Transmucosal Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer